Annual report
2206.TEDINET S100U77X
Period2023-01-01 → 2023-12-31
Filed2024-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100T44E. Amended by S100U88C (2024-08-14).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥332.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥303.9bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥338.6bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥344.0bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥288.2bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥18.6bn | 2023-01-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥12.8bn | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥21.3bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥13.6bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥21.7bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥19.6bn | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥17.0bn | 2019-01-01 → 2019-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥19.9bn | 2023-01-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥13.9bn | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥14.1bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥8.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥13.5bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.8bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥12.0bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥14.2bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥8.2bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥395.7bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥369.1bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥356.7bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥340.1bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥343.8bn | at 2019-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥132.6bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥124.3bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥263.1bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥244.8bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥241.2bn | at 2021-12-31d | Cons. | Net assets |
| Net assets / equity | ¥222.6bn | at 2020-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥220.9bn | at 2019-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥97.2bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥91.7bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥94.7bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥79.9bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥89.5bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥92.4bn | at 2020-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥98.0bn | at 2019-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥28.1bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥16.8bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥28.7bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥17.2bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥17.3bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥8.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥20.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥29.2bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥12.4bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥9.0bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥6.2bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥10.3bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.9bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥9.7bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥9.6bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥222.25 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥126.59 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥208.44 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥182.48 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥185.31 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥4,128.69 | at 2023-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,841.62 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,710.65 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,420.92 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,284.19 | at 2019-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 66.3% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.2% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.5% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.2% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.0% | at 2019-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.6% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.3% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.8% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.6% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 5,439 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 5,359 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 5,321 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 5,360 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 5,364 | at 2019-12-31d | Cons. | Number of employees |
| Revenue | ¥205.9bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥196.7bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥234.7bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥254.2bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥205.4bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥8.8bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | ¥7.5bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | ¥13.6bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥16.0bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥16.1bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥15.8bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.7bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥12.9bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥17.0bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | ¥9.8bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥12.6bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥10.3bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥10.6bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥9.5bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥317.0bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥301.7bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥297.0bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥294.2bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥294.5bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥97.2bn | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥90.7bn | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥219.7bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥211.1bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥208.7bn | at 2021-12-31d | Standalone | Net assets |
| Net assets / equity | ¥199.1bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥193.8bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥56.3bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥54.2bn | at 2022-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥154.91 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥196.19 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥159.17 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥162.81 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥146.32 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥80 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥65 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥3,455.46 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,319.49 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,216.73 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,072 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,985.01 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 69.3% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.0% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.3% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.7% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.8% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.6% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.1% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.9% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 68,468,000 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 68,468,000 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 68,468,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 68,468,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 68,468,000 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,405 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 1,411 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 1,424 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 1,448 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 1,525 | at 2019-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 113
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2023-01-01 → 2023-12-31 | ¥6.2bn |
| Reconciling Itemsreconciling | depreciation | 2023-01-01 → 2023-12-31 | ¥1.4bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-12-31 | −¥12.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-12-31 | −¥12.9bn |
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥196.9bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | ¥862m |
| Dairy Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥2.9bn |
| Dairy Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥3.5bn |
| Dairy Businessreportable segment | employees | at 2023-12-31 | 673 pure |
| Dairy Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥69.7bn |
| Dairy Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥69.7bn |
| Dairy Businessreportable segment | segment assets | at 2023-12-31 | ¥51.0bn |
| Dairy Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥529m |
| Food Ingredients Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥231m |
| Food Ingredients Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥223m |
| Food Ingredients Businessreportable segment | employees | at 2023-12-31 | 197 pure |
| Food Ingredients Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥13.6bn |
| Food Ingredients Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥13.3bn |
| Food Ingredients Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥301m |
| Food Ingredients Businessreportable segment | segment assets | at 2023-12-31 | ¥9.0bn |
| Food Ingredients Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥2.4bn |
| Health And Food Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥1.3bn |
| Health And Food Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥1.6bn |
| Health And Food Businessreportable segment | employees | at 2023-12-31 | 472 pure |
| Health And Food Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥50.5bn |
| Health And Food Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥50.5bn |
| Health And Food Businessreportable segment | segment assets | at 2023-12-31 | ¥26.3bn |
| Health And Food Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥2.1bn |
| Nutritional Confectionery Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥2.3bn |
| Nutritional Confectionery Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥2.7bn |
| Nutritional Confectionery Businessreportable segment | employees | at 2023-12-31 | 713 pure |
| Nutritional Confectionery Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥61.9bn |
| Nutritional Confectionery Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥61.9bn |
| Nutritional Confectionery Businessreportable segment | segment assets | at 2023-12-31 | ¥39.7bn |
| Nutritional Confectionery Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥6.5bn |
| Other Domestic Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥1.8bn |
| Other Domestic Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥1.5bn |
| Other Domestic Businessreportable segment | employees | at 2023-12-31 | 673 pure |
| Other Domestic Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥78.5bn |
| Other Domestic Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥66.0bn |
| Other Domestic Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥12.6bn |
| Other Domestic Businessreportable segment | segment assets | at 2023-12-31 | ¥22.4bn |
| Other Domestic Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥2.0bn |
| Overseas Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥5.3bn |
| Overseas Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥3.2bn |
| Overseas Businessreportable segment | employees | at 2023-12-31 | 1983 pure |
| Overseas Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥71.2bn |
| Overseas Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥71.2bn |
| Overseas Businessreportable segment | segment assets | at 2023-12-31 | ¥50.5bn |
| Overseas Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥4.2bn |
| —segment total | capex | 2023-01-01 → 2023-12-31 | ¥13.8bn |
| —segment total | depreciation | 2023-01-01 → 2023-12-31 | ¥12.6bn |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥345.5bn |
| —segment total | revenue external | 2023-01-01 → 2023-12-31 | ¥332.6bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥12.9bn |
| —segment total | segment assets | at 2023-12-31 | ¥198.8bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥17.8bn |
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥7.1bn |
| Reconciling Itemsreconciling | depreciation | 2022-01-01 → 2022-12-31 | ¥1.4bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-12-31 | −¥12.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-12-31 | −¥12.8bn |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥171.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | ¥2.4bn |
| Dairy Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥3.7bn |
| Dairy Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥3.4bn |
| Dairy Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥66.0bn |
| Dairy Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥66.0bn |
| Dairy Businessreportable segment | segment assets | at 2022-12-31 | ¥51.3bn |
| Dairy Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥267m |
| Food Ingredients Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥281m |
| Food Ingredients Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥206m |
| Food Ingredients Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥11.4bn |
| Food Ingredients Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥11.2bn |
| Food Ingredients Businessreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥226m |
| Food Ingredients Businessreportable segment | segment assets | at 2022-12-31 | ¥7.8bn |
| Food Ingredients Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥1.2bn |
| Health And Food Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥1.7bn |
| Health And Food Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥1.6bn |
| Health And Food Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥47.8bn |
| Health And Food Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥47.8bn |
| Health And Food Businessreportable segment | segment assets | at 2022-12-31 | ¥28.0bn |
| Health And Food Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥2.0bn |
| Nutritional Confectionery Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥3.2bn |
| Nutritional Confectionery Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥2.9bn |
| Nutritional Confectionery Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥57.8bn |
| Nutritional Confectionery Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥57.8bn |
| Nutritional Confectionery Businessreportable segment | segment assets | at 2022-12-31 | ¥38.0bn |
| Nutritional Confectionery Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥4.8bn |
| Other Domestic Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥2.4bn |
| Other Domestic Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥1.6bn |
| Other Domestic Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥73.8bn |
| Other Domestic Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥61.2bn |
| Other Domestic Businessreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥12.6bn |
| Other Domestic Businessreportable segment | segment assets | at 2022-12-31 | ¥17.9bn |
| Other Domestic Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥906m |
| Overseas Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥8.3bn |
| Overseas Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥2.8bn |
| Overseas Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥59.9bn |
| Overseas Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥59.9bn |
| Overseas Businessreportable segment | segment assets | at 2022-12-31 | ¥54.7bn |
| Overseas Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥1.2bn |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥19.7bn |
| —segment total | depreciation | 2022-01-01 → 2022-12-31 | ¥12.5bn |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥316.8bn |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥303.9bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥12.8bn |
| —segment total | segment assets | at 2022-12-31 | ¥197.7bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥10.4bn |
| Dairy Businessreportable segment | employees | at 2023-12-31 | 288 pure |
| Health And Food Businessreportable segment | employees | at 2023-12-31 | 261 pure |
| Nutritional Confectionery Businessreportable segment | employees | at 2023-12-31 | 279 pure |
| Other Domestic Businessreportable segment | employees | at 2023-12-31 | 10 pure |
| Overseas Businessreportable segment | employees | at 2023-12-31 | 3 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,041
| Item | Context | Value | Unit |
|---|---|---|---|
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row40Member | － | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row40Member | Original text (Japanese)無 | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income single statement (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Changes in scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Changes in scope of application of equity method (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding amounts of notes and accounts receivable trade and contract assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding write downs of inventories (text) | CurrentYearDuration | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding gain on sales of investment securities (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on covid19 (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reclassification adjustments and tax effects relating to other comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Notes leases consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes derivatives consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes retirement benefits consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes real estate for lease etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |